[{"address1": "777 Yamato Road", "address2": "Suite 502", "city": "Boca Raton", "state": "FL", "zip": "33431", "country": "United States", "phone": "561 589 7020", "website": "https://www.enterothera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the digestion of fats and other nutrients in CF and CP patients with EPI. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard Joel Paolone", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anna  Skowron", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1987, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4841, "open": 0.4793, "dayLow": 0.4618, "dayHigh": 0.4972, "regularMarketPreviousClose": 0.4841, "regularMarketOpen": 0.4793, "regularMarketDayLow": 0.4618, "regularMarketDayHigh": 0.4972, "payoutRatio": 0.0, "beta": 0.847, "forwardPE": -0.31513157, "volume": 50202, "regularMarketVolume": 50202, "averageVolume": 1635800, "averageVolume10days": 177930, "averageDailyVolume10Day": 177930, "bid": 0.5016, "ask": 0.5669, "bidSize": 1, "askSize": 1, "marketCap": 2282784, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 0.926, "fiftyDayAverage": 0.46216, "twoHundredDayAverage": 0.507, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 64740140, "profitMargins": 0.0, "floatShares": 4446092, "sharesOutstanding": 4765730, "sharesShort": 648698, "sharesShortPriorMonth": 286599, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1361, "heldPercentInsiders": 0.073020004, "heldPercentInstitutions": 0.02856, "shortRatio": 0.41, "shortPercentOfFloat": 0.1371, "impliedSharesOutstanding": 4765730, "bookValue": -1.095, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -22583624, "trailingEps": -8.07, "forwardEps": -1.52, "lastSplitFactor": "1:20", "lastSplitDate": 1702857600, "enterpriseToEbitda": -8.823, "52WeekChange": -0.29351032, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 0.479, "recommendationKey": "none", "totalCash": 59352, "totalCashPerShare": 0.012, "ebitda": -7337699, "totalDebt": 835609, "quickRatio": 0.002, "currentRatio": 2.904, "debtToEquity": 1.48, "returnOnAssets": -0.052059997, "returnOnEquity": -0.33243, "freeCashflow": -60628284, "operatingCashflow": -6289502, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ENTO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Entero Therapeutics Inc.", "longName": "Entero Therapeutics, Inc.", "regularMarketChangePercent": -1.0535, "regularMarketPrice": 0.479, "exchange": "NCM", "messageBoardId": "finmb_261738327", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1753477920, "regularMarketTime": 1753473600, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1476192600000, "postMarketChangePercent": 1.67014, "postMarketPrice": 0.487, "postMarketChange": 0.00799999, "regularMarketChange": -0.00510001, "regularMarketDayRange": "0.4618 - 0.4972", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1635800, "fiftyTwoWeekLowChange": 0.294, "fiftyTwoWeekLowChangePercent": 1.5891892, "fiftyTwoWeekRange": "0.185 - 0.926", "fiftyTwoWeekHighChange": -0.447, "fiftyTwoWeekHighChangePercent": -0.4827214, "fiftyTwoWeekChangePercent": -29.351032, "earningsTimestamp": 1747306740, "earningsTimestampStart": 1747306740, "earningsTimestampEnd": 1747306740, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.07, "epsForward": -1.52, "fiftyDayAverageChange": 0.01684001, "fiftyDayAverageChangePercent": 0.036437623, "twoHundredDayAverageChange": -0.028000027, "twoHundredDayAverageChangePercent": -0.055226874, "priceToBook": -0.4374429, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "AzurRx BioPharma, Inc.", "nameChangeDate": "2025-07-25", "cryptoTradeable": false, "displayName": "Entero Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]